The Effects of Salvia Hispanica-Enriched Foods on Glycemic and Insulinemic Responses and Subjective Satiety
NCT ID: NCT00728065
Last Updated: 2009-02-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2007-12-31
2009-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Salba & Flax on Postprandial Glycemia and Subjective Satiety
NCT02621307
Effectiveness and Safety of Salba on Weight Loss in Overweight Individuals With Type 2 Diabetes
NCT01403571
Effect of Chia Seeds (Salvia Hispanica L.) on Glucose Control in Patients With Type 2 Diabetes
NCT00362011
Beneficial Effect of Salicylates: Insulin Action, Secretion or Clearance?
NCT02007577
Effect of Medicago Sativa on Oral Glucose Tolerance in Healthy Adults
NCT03714438
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Results from preliminary studies confirm the satiating effects of Salvia hispanica, as they demonstrate that this grain induces increased subjective satiety and reduced postprandial glycemia. It is presumed that if a food is satiating, it will decrease subsequent intake of other foods because hunger is suppressed. A lower caloric intake, in turn, would help promote weight loss.
Salvia hispanica may also encourage weight loss via another mechanism. Preliminary studies suggested that this grain has a lower glycemic index value than white flour. Consumption of low-GI foods compared to high-GI foods has been suggested to reduce obesity by discouraging fat deposition and promoting fat oxidation . Thus, Salvia hispanica could potentially promote weight loss by reducing both hunger and the amount of body fat stored.
In order to study Salvia hispanica's ability to promote weight loss, feasibility studies must first be done to determine what amount is optimal for satiety and also whether enriched products are most satiating in liquid or solid form.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
White Bread (control)
White Bread
About 100g of white bread consisting of 50g of available carbohydrates, served with 250mL water
2
White Bread (control)
White Bread
About 100g of white bread consisting of 50g of available carbohydrates, served with 250mL water
3
White bread with 7.32 grams Salba hispanica
White bread with added 7.32g Salvia hispanica
About 100g of white bread consisting of 50g of available carbohydrates and 7.32g Salvia hispanica, served with 250mL water
4
White bread with 15.58 grams Salba hispanica
White bread with added 15.58g Salvia hispanica
About 100g of white bread consisting of 50g of available carbohydrates and 7.32g Salvia hispanica, served with 250mL water
5
White bread with 24 grams Salba hispanica
White bread with added Salvia hispanica
About 100g of white bread consisting of 50g of available carbohydrates and 24g Salvia hispanica, served with 250mL water
6
Rice Milk (control)
Rice milk
Rice milk containing 50g of available carbohydrates
7
Rice Milk (control)
Rice milk
Rice milk containing 50g of available carbohydrates
8
Rice Milk with 7.32 grams Salba hispanica
Enriched rice milk containing 7.32g Salvia hispanica
Rice milk containing 50g of available carbohydrates with 7.32g added Salvia hispanica
9
Rice Milk with 15.58 grams Salba hispanica
Enriched rice milk containing 15.58g Salvia hispanica
Rice milk containing 50g of available carbohydrates with 15.58g added Salvia hispanica
10
Rice Milk with 24 grams Salba hispanica
Enriched rice milk containing 24g Salvia hispanica
Rice milk containing 50g of available carbohydrates with 24g added Salvia hispanica
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
White Bread
About 100g of white bread consisting of 50g of available carbohydrates, served with 250mL water
White bread with added 7.32g Salvia hispanica
About 100g of white bread consisting of 50g of available carbohydrates and 7.32g Salvia hispanica, served with 250mL water
White bread with added 15.58g Salvia hispanica
About 100g of white bread consisting of 50g of available carbohydrates and 7.32g Salvia hispanica, served with 250mL water
White bread with added Salvia hispanica
About 100g of white bread consisting of 50g of available carbohydrates and 24g Salvia hispanica, served with 250mL water
Rice milk
Rice milk containing 50g of available carbohydrates
Enriched rice milk containing 7.32g Salvia hispanica
Rice milk containing 50g of available carbohydrates with 7.32g added Salvia hispanica
Enriched rice milk containing 15.58g Salvia hispanica
Rice milk containing 50g of available carbohydrates with 15.58g added Salvia hispanica
Enriched rice milk containing 24g Salvia hispanica
Rice milk containing 50g of available carbohydrates with 24g added Salvia hispanica
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy
* Use of drugs that influence carbohydrate metabolism (e.g. systemic glucocorticoids, beta blockers, thiazide diuretics)
* Use of fiber supplements
* Substance abuse (including regular smoking)
* Digestive or malabsorption disorders (malabsorption syndrome, Crohn's disease, stomach ulcer, duodenal ulcer or intestinal parasites)
* Presence of any significant disease or condition, including emotional or psychiatric disorders, that, in the opinion of the investigator, is likely to alter the metabolic state or interfere with the subject's ability to complete the study
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unity Health Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Clinical Nutrition and Risk Factor Modification Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Nutrition and Risk Factor Modification Centre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07-121
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.